Trial Profile
Prevalence and predictors of important telaprevir drug interactions among patients coinfected with hepatitis C and human immunodeficiency virus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Vertex Pharmaceuticals
- 04 Dec 2015 New trial record